27.73USD-5.16%Mkt Cap: 1.92B $P/E: —1d ago
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutane…
Industry Peers
Medical Instruments & Suppliesvs Medical Instruments & Supplies
P/B
Pricier
1M Perf
Lower
$140.84BUSDP/E 48.3
$82.06BUSDP/E 32.9
$70.27BUSDP/E 34.6
$41.70BUSDP/E 26.4
$30.39BUSDP/E 40.4
$28.27BUSDP/E 18.8
$25.36BUSDP/E 48.0
$19.36BUSDP/E 47.7
$19.20BUSDP/E 65.8
$17.23BUSDP/E 97.7
$14.10BUSDP/E 79.9
$13.99BUSDP/E 60.8
$13.36BUSDP/E 9.4
$12.22BUSDP/E 39.9
$12.08BUSDP/E 28.3
$11.01BUSD
$7.99BUSDP/E 21.4
$7.70BUSDP/E 151.6
$6.76BUSD
$5.47BUSDP/E 22.4
$5.61BUSDP/E 2112.7
$4.57BUSDP/E 30.7
$4.29BUSDP/E 64.3
$4.20BUSD
$4.14BUSDP/E 29.9
$3.91BUSDP/E 17.5
$3.53BUSDP/E 35.5
$3.72BUSDP/E 3034.0
$3.66BUSDP/E 78.8
$2.83BUSDP/E 18.2
$2.53BUSDP/E 19.4
$2.34BUSD
$2.19BUSDP/E 35.3
$2.13BUSD
$1.90BUSDP/E 35.1
$1.49BUSD
$1.32BUSDP/E 76.6
$1.43BUSD
$1.42BUSD
$1.38BUSD
$1.18BUSD
$1.04BUSDP/E 40.9
$958.82MUSD
$734.26MUSDP/E 15.6
$730.84MUSDP/E 14.3
$661.20MUSDP/E 56.0
$590.13MUSDP/E 34.6
$537.56MUSD
$353.32MUSDP/E 17.0
$349.17MUSDP/E 20.5
$307.06MUSD
$245.96MUSDP/E 13.6
$222.60MUSDP/E 37.5
$208.68MUSDP/E 25.0
$219.63MUSDP/E 20.4
$216.18MUSDP/E 393.2
$193.41MUSDP/E 1.7
$192.92MUSD
$186.94MUSDP/E 16.1
$164.23MUSD
$168.11MUSD
$130.97MUSD
$115.74MUSD
$115.11MUSD
$113.02MUSDP/E 35.9
$60.10MUSDP/E 6.3
$59.94MUSD
$55.82MUSD
$42.24MUSDP/E 42.0
$38.76MUSDP/E 51.0
$31.09MUSD
$28.39MUSD
$27.74MUSD
$21.55MUSD
$23.39MUSDP/E 163.0
$16.19MUSD
$15.09MUSD
$14.74MUSD
$12.97MUSD
$12.62MUSD
$7.73MUSDP/E 13.3
$4.91MUSD
$4.99MUSD
$4.62MUSD
$465.9KUSD
$126.1KUSD
Indicators:|
Key Statistics
Company
Market Cap1.92B $
Enterprise Value1.86B $
Revenue (TTM)751.00K $
Gross Profit-189.00K $
Net Income (TTM)-72.78M $
Revenue/Share0.0110 USD
Last Price27.73 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees116
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS74587B1017
Valuation
P/E (Trailing)—
P/E (Forward)-25.44
PEG—
EV/EBITDA-24.32
EV/Revenue2474.06
P/S2555.51
P/B28.53
EPS (TTM)-1.10
EPS (Forward)-1.09
52W Range
12.5682% of range31.00
52W High31.00 USD
52W Low12.56 USD
Profitability
Gross Margin-54.00%
Oper. Margin-4775.56%
EBITDA Margin0.00%
Profit Margin-20794.57%
ROE-90.24%
ROA-76.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.12M $
CapEx (TTM)335.00K $
FCF Margin-3872.19%
FCF Yield-1.52%
Net Debt-61.16M $
Net Debt/EBITDA0.80
Balance Sheet
Debt/Equity0.09
Current Ratio7.26
Quick Ratio6.99
Book Value/Sh0.9720 USD
Cash/Share0.9870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)30.67 USD
Upside (mean)+10.6%
Target Range30.00 USD – 32.00 USD
$30.00+10.6% to mean$32.00
# Analysts3
Ownership
Shares Out.69.21M
Float18.48M
Insiders73.38%
Institutions11.56%
Short Interest
Short Ratio8.6d
Short % Float14.67%
Short % Out.4.07%
Shares Short2.82M
Short (prev mo.)3.22M
Technical
SMA 5024.20 (+14.6%)
SMA 20018.98 (+46.1%)
Beta1.66
S&P 52W Chg20.05%
Avg Vol (30d)324.42K
Avg Vol (10d)443.53K
Technical Indicators
RSI (14)57.9
MACD1.0024
MACD Signal0.7911
MACD Hist.+0.2113
BB Upper28.73 USD
BB Middle26.03 USD
BB Lower23.32 USD
BB Width20.78%
ATR (14)1.969 USD
Vol Ratio (20d)0.78x